![Table 2 from Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence | Semantic Scholar Table 2 from Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/30a807d21caddb62b9e22272bed34f1929918dcc/7-Table2-1.png)
Table 2 from Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence | Semantic Scholar
![Prognostic role of β‐blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database - Paolillo - 2017 - European Journal of Heart Failure - Wiley Online Library Prognostic role of β‐blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database - Paolillo - 2017 - European Journal of Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6c7fa858-9265-40c3-aa06-bf985315b058/ejhf775-fig-0001-m.jpg)
Prognostic role of β‐blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database - Paolillo - 2017 - European Journal of Heart Failure - Wiley Online Library
![Table 5 from Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). | Semantic Scholar Table 5 from Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/756f1a156300486fff78e90803b94ee14c5b9b76/7-Table5-1.png)
Table 5 from Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). | Semantic Scholar
![Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers Patel RS, Sharma KH, Kamath NA, Patel NH, Thakkar AM - Indian J Pharmacol Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers Patel RS, Sharma KH, Kamath NA, Patel NH, Thakkar AM - Indian J Pharmacol](https://www.ijp-online.com/articles/2014/46/5/images/Indian%20J%20Pharmacol_2014_46_5_485_140577_t2.jpg)
Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers Patel RS, Sharma KH, Kamath NA, Patel NH, Thakkar AM - Indian J Pharmacol
![Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial | Semantic Scholar Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/91fe0292f4ac6e62b247a156b06280b9a441603d/5-Table3-1.png)
Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial | Semantic Scholar
![Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol) - ScienceDirect Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002914912024642-gr2.jpg)
Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol) - ScienceDirect
![Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol) - ScienceDirect Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002914912024642-gr4.jpg)